Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA User Fee Reauthorization Charges Along With Senate Passage

This article was originally published in The Gray Sheet

Executive Summary

FDA user fee and reform bill sails through Senate on 96-1 vote. House plans to take up its similar legislation this week.


Related Content

Congress Enters Final Stages On FDA Reform Bill
Senate FDA Bill: Device Provisions
Latest Senate FDA Reform Bill Would Delay Guidance On Mobile Health Apps
Public Hearing: IRS Tight-Lipped On Industry Device Tax Concerns
Fireworks Kept At Bay As Congress Pushes To Enact FDA Reforms By July 4
Senate Committee Moves Bipartisan FDA Reform Bill Toward Floor
Regulatory News In Brief
Device Industry Expects Quicker Path To Market In Exchange For Doubling Of User Fees NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts